Drugs / ENC0653
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07684196 | Jun → Oct 2026 expected | — | EnnovaBio | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ENC0653 | “A First-in-Human SAD/MAD Study to Evaluate Safety, Tolerability and PK of ENC0653 Ointment in Healthy Adult Subjects” NCT07684196 ↗ |
| Route | Topical | “following single and multiple topical dermal administration in healthy adult subjects” NCT07684196 ↗ |